Abstract
Bone-marrow-derived stem cells have displayed the potential for myocardial regeneration in animal models as well as in clinical trials. Unfractionated bone marrow mononuclear cell (MNC) population is a heterogeneous group of cells known to include a number of stem cell populations. Cells in the side population (SP) fraction have a high capacity for differentiation into multiple lineages. In the current study, we investigated the role of murine and human bone-marrow-derived side population cells in myocardial regeneration. In these studies, we show that mouse bone-marrow-derived SP cells expressed the contractile protein, alpha-actinin, following culture with neonatal cardiomyocytes and after delivery into the myocardium following injury. Moreover, the number of green-fluorescent-protein-positive cells, of bone marrow side population origin, increased progressively within the injured myocardium over 90 days. Transcriptome analysis of these bone marrow cells reveals a pattern of expression consistent with immature cardiomyocytes. Additionally, the differentiation capacity of human granulocyte colony-stimulating factor stimulated peripheral blood stem cells were assessed following injection into injured rat myocardium. Bone marrow mononuclear cell and side population cells were both readily identified within the rat myocardium 1 month following injection. These human cells expressed human-specific cardiac troponin I as determined by immunohistochemistry as well as numerous cardiac transcripts as determined by polymerase chain reaction. Both human bone marrow mononuclear cells and human side population cells augmented cardiac systolic function following a modest drop in function as a result of cryoinjury. The augmentation of cardiac function following injection of side population cells occurred earlier than with bone marrow mononuclear cells despite the fact that the number of side population cells used was one tenth that of bone marrow mononuclear cells (9 × 105 cells per heart in the MNC group compared to 9 × 104 per heart in the SP group). These results support the hypotheses that rodent and human-bone-marrow derived side population cells are capable of acquiring a cardiac fate and that human bone-marrow-derived side population cells are superior to unfractionated bone marrow mononuclear cells in augmenting left ventricular systolic function following cryoinjury.
Similar content being viewed by others
Reference
Assmus, B., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine, 355(12), 1222–1232.
Ince, H., et al. (2005). Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation, 112(9 Suppl), I73–I80.
Janssens, S., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet, 367(9505), 113–121.
Kang, H. J., et al. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114(1 Suppl), I145–I151.
Lunde, K., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1199–1209.
Meyer, G. P., et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10), 1287–1294.
Schachinger, V., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1210–1221.
Wollert, K. C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–148.
Menasche, P. (2007). Cellular therapy in thoracic and cardiovascular disease. Annals of Thoracic Surgery, 84(1), 339–342.
Boyle, A. J., et al. (2006). Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation, 114(4), 339–352.
Fraser, A. R., et al. (2006). Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. Journal of Leukocyte Biology, 80(4), 862–869.
Goodell, M. A., et al. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine, 183(4), 1797–1806.
Goodell, M. A., et al. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Natural Medicines, 3(12), 1337–1345.
Gussoni, E., et al. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 401(6751), 390–394.
Jackson, K. A., Mi, T., & Goodell, M. A. (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America, 96(25), 14482–14486.
Martin, C. M., et al. (2004). Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Developmental Biology, 265(1), 262–275.
Bunting, K. D. (2002). ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells, 20(1), 11–20.
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002). The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 99(2), 507–512.
Molkentin, J. D., et al. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93(2), 215–228.
Naseem, R. H., et al. (2007). Reparative myocardial mechanisms in adult C57BL/6 and MRL mice following injury. Physiological Genomics, 30, 44–52.
Gallardo, T. D., Hammer, R. E., & Garry, D. J. (2003). RNA amplification and transcriptional profiling for analysis of stem cell populations. Genesis, 37(2), 57–63.
Masino, A. M., et al. (2004). Transcriptional regulation of cardiac progenitor cell populations. Circulation Research, 95(4), 389–397.
Goetsch, S. C., et al. (2003). Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiological Genomics, 14(3), 261–271.
Garry, D. J., et al. (1997). Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Developmental Biology, 188(2), 280–294.
Cheng, T. C., et al. (1993). Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science, 261(5118), 215–218.
Martin, C. M., et al. (2008). Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells. Circulation Research, 102(9), 1075–1081.
Pfister, O., et al. (2005). CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circulation Research, 97(1), 52–61.
Beltrami, A. P., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.
Matsuura, K., et al. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. Journal of Biological Chemistry, 279(12), 11384–11391.
Bittner, R. E., et al. (1999). Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anatomy and Embryology (Berl), 199(5), 391–396.
Jackson, K. A., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Journal of Clinical Investigation, 107(11), 1395–1402.
Orlic, D., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701–705.
Acknowledgements
The authors acknowledge the technical assistance provided by Maggie Robeldo, Caroline Humphries, Sean Goetsch, and Nan Jiang.
Sources of Funding
Funding was provided by the GlaxoSmithKline (CMM), American Heart Association (DJG, HAS), and March of Dimes Associations (DJG).
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Sadek and Martin contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Sadek, H.A., Martin, C.M., Latif, S.S. et al. Bone-Marrow-Derived Side Population Cells for Myocardial Regeneration. J. of Cardiovasc. Trans. Res. 2, 173–181 (2009). https://doi.org/10.1007/s12265-009-9090-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9090-0